文献
J-GLOBAL ID:202002213720769485
整理番号:20A0765243
2010年から2018年までの3つの調節機関による抗腫瘍薬の試験集団と承認された治療適応の間の差異に関する定性的研究【JST・京大機械翻訳】
A Qualitative Study on the Differences Between Trial Populations and the Approved Therapeutic Indications of Antineoplastic Agents by 3 Regulatory Agencies From 2010 to 2018
著者 (6件):
Sumi Eriko
(Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan)
,
Asada Ryuta
(Innovative and Clinical Research Promotion Center, Graduate School of Medicine, Gifu University, Gifu, Japan)
,
Lu Ying
(Department of Biomedical Data Science, Stanford University, Stanford, CA, USA)
,
Ito-Ihara Toshiko
(The Clinical and Translational Research Center, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan)
,
Grimes Kevin V.
(Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA)
,
Grimes Kevin V.
(SPARK Translational Research Program, Stanford University School of Medicine, Stanford, CA, USA)
資料名:
Clinical Therapeutics
(Clinical Therapeutics)
巻:
42
号:
2
ページ:
305-320.e0
発行年:
2020年
JST資料番号:
A1157A
ISSN:
0149-2918
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)